ARS Pharmaceuticals, Inc. is a startup based in Israel, 3 tracked investors.
ARS Pharmaceuticals, Inc. is a startup founded in 2014 based in Israel. Brouky records 3 investors associated with the company.
Develops needle-free, intranasal epinephrine (neffy™ / ARS-1) for the treatment of severe allergic reactions and anaphylaxis, aiming to provide a portable, easy-to-use alternative to injectable epinephrine. The company is focused on patient-friendly delivery solutions to address needle-related risks and ease of use.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.